News

Boehringer Ingelheim’s strong first-half 2025 results, with 6.3% net sales growth reaching €14.0 billion, underscore the company’s diversified portfolio...

Roche’s Half-Year Results Showcase Oncology Strength, Pipeline Progress, and Strategic Shifts Roche reported robust 7% sales growth (CER) for...

Roche’s H1 2025 results reveal robust growth driven by strong pharmaceutical sales, underscoring the company’s continued success in navigating...

Opus Genetics has forged a strategic partnership with the global RDH12 Alliance to accelerate the development of OPGX-RDH12, a...

Plus Therapeutics Secures $1.6M Advance Payment for Leptomeningeal Cancer Program, Reinforcing Targeted Radiotherapy’s Rise Plus Therapeutics has received a...

Bio Usawa Biotechnology and Servaregmp are partnering to establish advanced monoclonal antibody (mAb) manufacturing capabilities in Africa. This ambitious...

ANI Pharmaceuticals announced results from its NEW DAY clinical trial evaluating the supplemental injection needs of patients with diabetic...

Rakovina Therapeutics has announced promising preclinical results for its AI-driven KT-5000AI program, focused on developing selective ATR inhibitors for...

Eupraxia Pharmaceuticals is hitting the investor conference circuit, showcasing its proprietary Diffusphere™ drug delivery technology at several key events...

Supernus Pharmaceuticals is set to announce its second-quarter 2025 financial results on August 5th, offering a critical glimpse into...